Philippe Schultz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Philippe Schultz has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Bertrand Baujat
Sorbonne University, APHP, Department of ENT-Head and Neck Surgery, Tenon Hospital, 4 rue de la chine, 75020, Paris, France
2 shared publications - Sarah Atallah
Young Confederation of European ORL‐HNS, Y‐CEORL‐HNS Vienna Austria
2 shared publications A. Bozec
1 shared publicationA. Damecourt
1 shared publication- A.R. Pérouse1 shared publication
- Anne Auperin
Gustave Roussy 4 Biostatistics and Epidemiology Office Inserm U1018 Oncostat, Ligue Contre le Cancer, University Paris-Saclay, Villejuif, France
1 shared publication
Latest Publications
- Open Access
- 9 December 2022
- Published by Wiley in Clinical and Translational Allergy
- Vol. 12 (12) , e12211
Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
Background: Dysphonia is a frequent comorbidity of asthma and has been suggested to be a local side effect of inhaled corticosteroids due to laryngeal candidiasis. We hypothesized that dysphonia in asthmatics was not due to laryngeal organic lesions but to laryngeal dysfunction during phonation (LDP).Objective: We compared the frequency of LDP in female asthmatic patients treated with inhaled corticosteroids to female controls.Methods: We compared 68 asthmatic female patients to 53 female control subjects. Pulmonary function tests were performed and the asthmatic patients classified according to the level of inhaled corticosteroids. Dysphonia was defined as a Vocal Handicap Index ≥18 or GRBAS score ≥2. All patients underwent video laryngo‐strobe examination, analyzed blindly and separately by two otolaryngologists, describing mucosal changes, LDP, or Organic lesions linked to Laryngeal Dysfunction during Phonation (OLDP).Results: 66.2% of the asthmatic patients exhibited dysphonia and 11.3% of controls (p < 0.001). No laryngeal candidiasis was found, only 3 patients presented laryngeal mucosa inflammation. LDP was observed in 60.3% of asthmatic patients and 18.9% of controls (p < 0.001), and no difference was found for OLDP (11.8% vs. 13.2%). No association was made between LDP, the dosage of inhaled corticosteroid, and bronchial obstruction.Conclusions: Asthmatic patients were more dysphonic than control subjects. This phenomenon was not explained by mucosal inflammation, laryngeal candidiasis or OLDP. Asthmatic patients had more LDP than controls. There was no relation between LDP, inhaled corticosteroids dosage or bronchial obstruction. These results change our view of inhaled corticosteroid side effects in female asthmatic patients.
- 9 December 2022
- Published by Wiley in Clinical and Translational Allergy
- Vol. 12 (12) , e12211
Open AccessLaryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
Background: Dysphonia is a frequent comorbidity of asthma and has been suggested to be a local side effect of inhaled corticosteroids due to laryngeal candidiasis. We hypothesized that dysphonia in asthmatics was not due to laryngeal organic lesions but to laryngeal dysfunction during phonation (LDP).Objective: We compared the frequency of LDP in female asthmatic patients treated with inhaled corticosteroids to female controls.Methods: We compared 68 asthmatic female patients to 53 female control subjects. Pulmonary function tests were performed and the asthmatic patients classified according to the level of inhaled corticosteroids. Dysphonia was defined as a Vocal Handicap Index ≥18 or GRBAS score ≥2. All patients underwent video laryngo‐strobe examination, analyzed blindly and separately by two otolaryngologists, describing mucosal changes, LDP, or Organic lesions linked to Laryngeal Dysfunction during Phonation (OLDP).Results: 66.2% of the asthmatic patients exhibited dysphonia and 11.3% of controls (p < 0.001). No laryngeal candidiasis was found, only 3 patients presented laryngeal mucosa inflammation. LDP was observed in 60.3% of asthmatic patients and 18.9% of controls (p < 0.001), and no difference was found for OLDP (11.8% vs. 13.2%). No association was made between LDP, the dosage of inhaled corticosteroid, and bronchial obstruction.Conclusions: Asthmatic patients were more dysphonic than control subjects. This phenomenon was not explained by mucosal inflammation, laryngeal candidiasis or OLDP. Asthmatic patients had more LDP than controls. There was no relation between LDP, inhaled corticosteroids dosage or bronchial obstruction. These results change our view of inhaled corticosteroid side effects in female asthmatic patients.
- 1 December 2021
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 138 (6) , 472-474
Spasme laryngé et trachéotomie après injection intracordale d’hydroxylapatite
- 1 December 2021
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 138 (6) , 472-474
Spasme laryngé et trachéotomie après injection intracordale d’hydroxylapatite
- 1 April 2021
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 138 (2) , 90-97
Évaluation fonctionnelle des reconstructions mandibulaires par lambeaux libres osseux. Une étude GETTEC
- 1 April 2021
- Published by Elsevier in Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale
- Vol. 138 (2) , 90-97
Évaluation fonctionnelle des reconstructions mandibulaires par lambeaux libres osseux. Une étude GETTEC
- Top Cited Papers
- 1 May 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 130, 241-249
A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors
- 1 May 2020
- Published by Elsevier in European Journal of Cancer
- Vol. 130, 241-249
Top Cited PapersA prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors